Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
90.30
+2.50 (2.85%)
Mar 4, 2026, 11:43 AM EST - Market open
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $5.45 billion as of March 4, 2026. Its market cap has increased by 126.83% in one year.
Market Cap
5.45B
Enterprise Value
5.23B
1-Year Change
126.83%
Ranking
Category
Stock Price
$90.30
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $5.45B, an increase of 1,733.23%. That is a compound annual growth rate of 55.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 5.30B | 29.77% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 6.12B |
| Cogent Biosciences | 6.00B |
| Protagonist Therapeutics | 5.83B |
| CRISPR Therapeutics AG | 5.57B |
| Caris Life Sciences | 5.48B |
| Immunovant | 5.44B |
| PTC Therapeutics | 5.33B |
| CG Oncology | 5.11B |